Yusuke Echigoya

Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy

Yusuke Echigoya, Akinori Nakamura, Tetsuya Nagata et al. · Proceedings of the National Academy of Sciences · 2017 · 116 citations · Full text

Medicine, Cardiology, Molecular Biology +16

Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy

Yusuke Echigoya, Kenji Rowel Q. Lim, Nhu Trieu et al. · Molecular Therapy · 2017 · 87 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +5

Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice

Yusuke Echigoya, Yoshitsugu Aoki, Bailey Miskew et al. · Molecular Therapy — Nucleic Acids · 2015 · 82 citations · Full text

Medicine, Molecular Medicine, Pharmacology +13

Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy

Akinori Nakamura, Naoko Shiba, Daigo Miyazaki et al. · Journal of Human Genetics · 2016 · 72 citations

Life Sciences, Genetics, Molecular Genetics +13

Extensive and Prolonged Restoration of Dystrophin Expression with Vivo-Morpholino-Mediated Multiple Exon Skipping in Dystrophic Dogs

Toshifumi Yokota, Akinori Nakamura, Tetsuya Nagata et al. · Nucleic Acid Therapeutics · 2012 · 70 citations · Full text

Medicine, Biotechnology, Molecular Genetics +12